Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II trial of oxaliplatin with docetaxel followed by epidermal growth factor antibody (EGFR-AB) cetuximab in patients with recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN)

Next Previous
Trial Profile

Phase II trial of oxaliplatin with docetaxel followed by epidermal growth factor antibody (EGFR-AB) cetuximab in patients with recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN)

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 10 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cetuximab (Primary) ; Docetaxel (Primary) ; Oxaliplatin (Primary)
  • Indications Head and neck cancer
  • Focus Therapeutic Use

Most Recent Events

  • 06 Aug 2012 Actual end date (Apr 2012) added as reported by ClinicalTrials.gov.
  • 02 Mar 2011 Planned end date changed from 1 Jan 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.
  • 23 Sep 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top